Quarterly report pursuant to Section 13 or 15(d)

Debt - Narrative (Details)

v3.20.2
Debt - Narrative (Details)
1 Months Ended 3 Months Ended 6 Months Ended 48 Months Ended
Feb. 25, 2020
USD ($)
Feb. 20, 2019
USD ($)
Jan. 30, 2013
USD ($)
Feb. 28, 2019
USD ($)
day
$ / shares
shares
Feb. 28, 2018
USD ($)
$ / shares
Nov. 30, 2015
USD ($)
Jan. 31, 2013
Dec. 31, 2019
USD ($)
institution
Jun. 30, 2020
USD ($)
institution
shares
Jun. 30, 2019
USD ($)
Dec. 31, 2016
USD ($)
shares
Feb. 01, 2019
USD ($)
Nov. 08, 2018
USD ($)
Debt Instrument [Line Items]                          
Credit line capacity                 $ 101,312,000        
Repayments of lines of credit                 382,374,000 $ 78,824,000      
Long-term line of credit, noncurrent               $ 44,749,000 51,489,000        
Goodwill               $ 671,940,000 $ 671,599,000        
Number of financial institutions | institution               11 11        
BioReference                          
Debt Instrument [Line Items]                          
Net assets                 $ 913,200,000        
Goodwill                 434,800,000        
Intangible assets                 $ 345,900,000        
OPKO Health Europe                          
Debt Instrument [Line Items]                          
Weighted average interest rate               2.60% 2.60%        
Minimum                          
Debt Instrument [Line Items]                          
Consecutive days               30 days          
Minimum | OPKO Health Europe                          
Debt Instrument [Line Items]                          
Variable interest rates                 0.70%        
Maximum                          
Debt Instrument [Line Items]                          
Percentage of total revolving commitment               10.00%          
Maximum | OPKO Health Europe                          
Debt Instrument [Line Items]                          
Variable interest rates                 3.80%        
Line of Credit                          
Debt Instrument [Line Items]                          
Weighted average interest rate               4.00% 4.20%        
Convertible Debt                          
Debt Instrument [Line Items]                          
Interest rate on notes payable       4.50%                  
Convertible Debt | Convertible Senior Notes Due 2025                          
Debt Instrument [Line Items]                          
Debt face amount       $ 200,000,000.0                  
Debt instrument, conversion ratio       0.2367424                  
Conversion price per share (in dollars per share) | $ / shares       $ 4.22                  
Shares issuable under debt agreement (in shares) | shares       30,000,000                  
Shares issued on converted debt (in shares) | shares                 29,250,000        
Proceeds one-time nominal fee                 $ 300,000        
Equity component of convertible debt       $ 52,600,000                  
Effective interest rate                 11.20%        
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period one                          
Debt Instrument [Line Items]                          
Convertible debt, threshold percentage of stock price trigger       130.00%                  
Equivalent redemption price       100.00%                  
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period one | Minimum                          
Debt Instrument [Line Items]                          
Number of trading days | day       20                  
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period one | Maximum                          
Debt Instrument [Line Items]                          
Number of consecutive trading days applicable conversion price | day       30                  
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period two                          
Debt Instrument [Line Items]                          
Convertible debt, threshold percentage of stock price trigger       98.00%                  
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period two | Minimum                          
Debt Instrument [Line Items]                          
Number of trading days | day       5                  
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period two | Maximum                          
Debt Instrument [Line Items]                          
Number of consecutive trading days applicable conversion price | day       5                  
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period three                          
Debt Instrument [Line Items]                          
Convertible debt, threshold percentage of stock price trigger       130.00%                  
Equivalent redemption price       100.00%                  
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period three | Minimum                          
Debt Instrument [Line Items]                          
Number of trading days | day       20                  
Convertible Debt | Convertible Senior Notes Due 2025 | Redemption period three | Maximum                          
Debt Instrument [Line Items]                          
Number of consecutive trading days applicable conversion price | day       30                  
Convertible Debt | 5% Convertible Notes                          
Debt Instrument [Line Items]                          
Interest rate on notes payable         5.00%                
Debt face amount         $ 55,000,000.0                
Conversion price per share (in dollars per share) | $ / shares         $ 5.00                
Debt instrument, term         5 years                
Minimum conversion notice         30 days                
Maximum conversion notice         60 days                
Convertible Debt | Notes Due February 1, 2033                          
Debt Instrument [Line Items]                          
Converted debt amount                     $ 143,200,000    
Senior Notes                          
Debt Instrument [Line Items]                          
Remaining principal               $ 148,140,000 $ 152,018,000        
Senior Notes | Notes Due February 1, 2033                          
Debt Instrument [Line Items]                          
Interest rate on notes payable     3.00%                    
Debt face amount     $ 175,000,000.0                    
Equivalent redemption price     100.00%                    
Notes | Notes Due February 1, 2033                          
Debt Instrument [Line Items]                          
Equivalent redemption price             100.00%            
Debt repurchase amount                       $ 28,800,000  
Remaining principal                       $ 3,000,000.0  
Line of Credit | Unsecured Debt                          
Debt Instrument [Line Items]                          
Credit line capacity $ 100,000,000                       $ 60,000,000
Interest rate on notes payable 11.00%                       10.00%
Revolving Credit Facility | Line of Credit | New Credit Agreement                          
Debt Instrument [Line Items]                          
Credit line capacity           $ 75,000,000.0              
Commitment fee (as a percent) 0.25%                        
Remaining borrowing capacity                 15,300,000        
Commitment fee percentage           0.25%              
Long-term line of credit, noncurrent                 $ 51,500,000        
Swingline | Line of Credit | New Credit Agreement                          
Debt Instrument [Line Items]                          
Credit line capacity           $ 20,000,000.0              
Letter of Credit | Line of Credit | New Credit Agreement                          
Debt Instrument [Line Items]                          
Credit line capacity           $ 20,000,000.0              
LIBOR | Revolving Credit Facility | Line of Credit | New Credit Agreement                          
Debt Instrument [Line Items]                          
Basis spread on variable rate           2.50%              
LIBOR, First 12 Months | Revolving Credit Facility | Line of Credit | New Credit Agreement                          
Debt Instrument [Line Items]                          
Basis spread on variable rate           0.35%              
LIBOR Thereafter | Revolving Credit Facility | Line of Credit | New Credit Agreement                          
Debt Instrument [Line Items]                          
Basis spread on variable rate           0.50%              
LIBOR, First 12 Months, Adjusted for Eurocurrency Liabilities | Revolving Credit Facility | Line of Credit | New Credit Agreement                          
Debt Instrument [Line Items]                          
Basis spread on variable rate           1.35%              
LIBOR, Thereafter, Adjusted for Eurocurrency Liabilities | Revolving Credit Facility | Line of Credit | New Credit Agreement                          
Debt Instrument [Line Items]                          
Basis spread on variable rate           1.50%              
Common Stock | Convertible Debt | Notes Due February 1, 2033                          
Debt Instrument [Line Items]                          
Shares issued on converted debt (in shares) | shares                     21,539,873    
Dr Frost | Line of Credit | Unsecured Debt                          
Debt Instrument [Line Items]                          
Credit line capacity                         $ 60,000,000
Repayments of lines of credit   $ 28,800,000